AI Tokens
Stock Analysis on Net

Biogen Inc. (NASDAQ:BIIB)

This company has been moved to the archive! The financial data has not been updated since October 25, 2022.

Common-Size Balance Sheet: Assets

Biogen Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Cash and cash equivalents 9.47 5.41 10.70 4.84 6.65
Marketable securities 6.45 5.19 5.74 9.15 8.94
Accounts receivable, net 6.49 7.77 6.90 7.74 7.56
Due from anti-CD20 therapeutic programs 1.73 1.68 2.17 2.08 2.25
Inventory 5.66 4.34 2.95 3.68 3.82
Other current assets 3.10 3.58 2.32 2.72 4.07
Current assets 32.90% 27.97% 30.78% 30.21% 33.29%
Marketable securities 3.74 3.14 5.17 5.44 12.93
Property, plant and equipment, net 14.31 13.86 11.92 14.24 13.45
Operating lease assets 1.57 1.76 1.57 0.00 0.00
Intangible assets, net 9.30 12.53 12.95 12.34 16.40
Goodwill 24.13 23.41 21.14 22.56 19.59
Deferred tax asset 5.93 5.56 11.87 8.52 2.52
Investments and other assets 8.12 11.78 4.60 6.69 1.82
Long-term assets 67.10% 72.03% 69.22% 69.79% 66.71%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).


The asset composition of the entity shows a consistent distribution between current and long-term assets over the five-year period from 2017 to 2021. Current assets generally represent approximately 30% of the total asset base, while long-term assets account for the remaining 70%, indicating a capital-intensive structure typical of the biotechnology sector.

Liquidity and Current Asset Management
Cash and cash equivalents exhibit significant volatility, fluctuating from a low of 4.84% in 2018 to a peak of 10.70% in 2019, ending at 9.47% in 2021. Short-term marketable securities have experienced a gradual decline from 8.94% to 6.45% over the period. Accounts receivable have remained relatively stable, oscillating between 6.49% and 7.77%. A modest upward trend is observed in inventory, which increased from 3.82% in 2017 to 5.66% in 2021, suggesting a potential increase in product stockpiling or a change in supply chain requirements.
Intangible Assets and Goodwill
There is a notable divergence between goodwill and other intangible assets. Goodwill has steadily increased as a percentage of total assets, rising from 19.59% in 2017 to 24.13% in 2021, which typically indicates growth through acquisitions. Conversely, net intangible assets have seen a marked decline, dropping from 16.40% in 2017 to 9.30% in 2021, likely reflecting the systematic amortization of acquired intellectual property.
Long-term Investment and Fixed Assets
Long-term marketable securities have decreased substantially, falling from 12.93% in 2017 to 3.74% in 2021, indicating a reallocation of capital away from long-term financial instruments. Property, plant, and equipment have remained consistent, averaging around 13-14% of total assets. Investments and other assets showed a significant increase from 1.82% in 2017 to a peak of 11.78% in 2020, before settling at 8.12% in 2021.
Tax and Lease Assets
Deferred tax assets experienced a period of growth, peaking at 11.87% in 2019 before returning to a range of 5.56% to 5.93% by 2021. Operating lease assets appeared in 2019 following accounting standard changes, maintaining a stable presence of approximately 1.57% of total assets through 2021.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?